Bedoradrine (MN-221) sulfate is a highly selective β2-adrenergic receptor agonist used for the research of asthma treatment; it effectively alleviates airway bronchospasm in asthma patients by relaxing airway smooth muscle and reducing airway inflammation, thereby improving respiratory function.